Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual's teeth
Abstract
The invention relates to a method for reducing the viability of detrimental oral microorganisms in an individual, said method comprising subjecting the individual's oral cavity to a bioactive glass, the average particle size of which is less than 100 μm. Furthermore, this invention concerns a method for the prevention of dental caries and/or gingivitis in an individual, said caries being caused by a cariogenic bacteria; or for prevention or treatment of periapical infections. Further the invention relates to a method for the whitening and/or mechanical cleaning of an individual's teeth.
Claims
exact text as granted — not AI-modified1 . A method for reducing the viability of detrimental oral microorganisms in an individual, said method comprising subjecting the individual's oral cavity to a bioactive glass, the average particle size of which is less than 100 μm.
2 . The method according to claim 1 , wherein the average particle size is less than 50 μm, preferably about 20 μm or less.
3 . The method according to claim 1 , wherein the bioactive glass is administered as a composition comprising particles of the bioactive glass admixed into water or an aqueous solution.
4 . The method according to claim 3 , wherein the composition is a paste comprising about 40 to 80 weight-% of bioactive glass.
5 . The method according to claim 1 , wherein the bioactive glass is selected from a bioactive glass having the composition SiO 2 53%; CaO 20%; P 2 O 5 4% and Na 2 O 23% by weight, or SiO 2 53%; CaO 20%; P 2 O 5 4%, Na 2 O 6%, K 2 O 12% and MgO 5% by weight.
6 . The method according to claim 1 , wherein the detrimental oral microorganisms are cariogenic bacteria.
7 . The method according to claim 6 , wherein the cariogenic bacteria are Actinomyces naeslundii and/or Streptococcus mutans.
8 . The method according to claim 1 , wherein the detrimental oral microorganisms are periodontal bacteria.
9 . The method according to claim 8 , wherein the periodontal bacteria are Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis.
10 . The method according to claim 1 , wherein the treatment is carried out for about 10 minutes.
11 . The method according to claim 1 , wherein the viability of benign oral microorganisms is reduced less than the viability of the detrimental oral microorganisms.
12 . The method according to claim 12 , wherein the benign oral microorganism is Streptococcus sanguis.
13 . A method for the prevention of dental caries and/or gingivitis in an individual, said caries being caused by a cariogenic bacteria, or for prevention or treatment of periapical infections, said method comprising subjecting the individual's oral cavity and/or root canals to a bioactive glass, the average particle size of which is less than 100 μm.
14 . The method according to claim 13 , wherein the average particle size is less than 50 μm, preferably about 20 μm or less.
15 . The method according to claim 13 , wherein the bioactive glass is administered as a composition comprising particles of the bioactive glass admixed into water or an aqueous solution.
16 . The method according to claim 15 , wherein the composition is a paste comprising about 40 to 80 weight-% of bioactive glass.
17 . The method according to claim 13 , wherein the bioactive glass is selected from a bioactive glass having the composition SiO 2 53%; CaO 20%; P 2 O 5 4% and Na 2 O 23% by weight, or SiO 2 53%; CaO 20%; P 2 O 5 4%, Na 2 O 6%, K 2 O 12% and MgO 5% by weight.
18 . The method according to claim 17 , wherein the cariogenic bacteria are Actinomyces naeslundii and/or Streptococcus mutans.
19 . The method according to claim 13 , wherein the treatment is carried out for about 10 minutes.
20 . A method for the whitening and/or mechanical cleaning of an individual's teeth, said method comprising subjecting the individual's oral cavity to a bioactive glass, the average particle size of which is less than 100 μm.
21 . The method according to claim 20 , wherein the average particle size is less than 50 μm, preferably about 20 μm or less.
22 . The method according to claim 20 , wherein the bioactive glass is administered as a composition comprising particles of the bioactive glass admixed into water or an aqueous solution.
23 . The method according to claim 22 , wherein the composition is a paste comprising about 40 to 80 weight-% of bioactive glass.
24 . The method according to claim 20 , wherein the bioactive glass is selected from a bioactive glass having the composition SiO 2 53%; CaO 20%; P 2 O 5 4% and Na 2 O 23% by weight, or SiO 2 53%; CaO 20%; P 2 O 5 4%, Na 2 O 6%, K 2 O 12% and MgO 5% by weight.Join the waitlist — get patent alerts
Track US2002114768A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.